September 12, 2001 · STOCK Act disclosure
Representative James R. Langevin (Democrat-RI) bought Alexion Pharmaceuticals, Inc., a stock transaction, valued at $15,001 - $50,000. The trade took place on September 12, 2001 and was disclosed on May 5, 2013 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.